Evidence map›Paper›PMID 28329348›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.

David Lebeaux, Romain Freund, Christian van Delden, Hélène Guillot, Sierk D Marbus, Marie Matignon, Eric Van Wijngaerden, Benoit Douvry, Julien De Greef, Fanny Vuotto and 11 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07013006 (Retrospective Study to Assess the Evolution of MRI or CT Lesions in Treated CNS Nocardiosis), which is not on this map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07013006 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Retrospective Study to Assess the Evolution of MRI or CT Lesions in Treated CNS Nocardiosis

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2025 to 2026Enrolled60ConditionsNocardiosisArmsCollection of data from the patient's medical file
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Synergistic and additive in vitro interactions of imipenem, trimethoprim-sulfamethoxazole, amikacin, and clofazimine against clinical isolates of Nocardia wallacei.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Case Report: Bloodstream infection withFrontiers in medicine · 2025
    Article
  12. First Documented Case of Pneumonia withInfection and drug resistance · 2025
    Article
  13. Article
  14. Article
  15. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  16. Open forum infectious diseases · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 5 countries.

David LebeauxUniversité Paris Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Centre d'Infectiologie Necker-Pasteur and Institut Imagine.
Romain FreundUniversité Paris Descartes, INSERM UMRS 1138 Team 22, and.
Christian van DeldenTransplant Infectious Diseases Unit, Hôpitaux Universitaires de Genève, Geneva, and.
Hélène GuillotSorbonne Universités, UPMC Université Paris 06, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Service des Maladies Infectieuses et Tropicales, France.
Sierk D MarbusDepartment of Infectious Diseases, Leiden University Medical Center, The Netherlands.
Marie MatignonAssistance Publique-Hôpitaux de Paris, Groupe Henri Mondor-Albert Chenevier, Nephrology and Transplantation Department, Centre d'Investigation Clinique-BioThérapies 504 and Institut National de la Santé et de la Recherche Médicale U955 and Paris Est University, Créteil, France.
Eric Van WijngaerdenDepartment of General Internal Medicine, University Hospitals Leuven, Belgium.
Benoit DouvryService de Pneumologie et de Transplantation Pulmonaire, Hôpital Foch, Suresnes, France.
Julien De GreefDepartment of Internal Medicine and Infectious Diseases, Saint-Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
Fanny VuottoInfectious Diseases Unit, Huriez Hospital, CHRU Lille, and.
Leïla TricotService de Néphrologie-Transplantation Rénale, Hôpital Foch, Suresnes, France.
Mario Fernández-RuizUnit of Infectious Diseases, University Hospital 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
Jacques DantalInstitut de Transplantation, d'Urologie et de Néphrologie, CHU Nantes, France.
Cédric HirzelSwiss Transplant Cohort Study, Basel, Switzerland.
Jean-Philippe JaisUniversité Paris Descartes, INSERM UMRS 1138 Team 22, and.
Veronica Rodriguez-NavaResearch Group on Bacterial Opportunistic Pathogens and Environment UMR5557 Écologie Microbienne, French Observatory of Nocardiosis, Université de Lyon 1, CNRS, VetAgro Sup, France; and.
Frédérique JacobsDivision of Infectious Diseases, CUB-Erasme, Université Libre de Bruxelles, Belgium.
Olivier LortholaryUniversité Paris Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Centre d'Infectiologie Necker-Pasteur and Institut Imagine.
Julien CoussementDivision of Infectious Diseases, CUB-Erasme, Université Libre de Bruxelles, Belgium.
European Study Group for Nocardia in Solid Organ Transplantation
European Study Group for Nocardia in Solid Organ Transplantation
Délégation Paris 5 · FRSorbonne Université · FRHôpital Foch · FRHôpital Necker-Enfants Malades · FRKU Leuven · BEHôpital Beau-Séjour · CHHôpital Claude Huriez · FRInserm · FRUniversité Libre de Bruxelles · BEInstitut de Transplantation Urologie en Nephrologie · FRLeiden University Medical Center · NLResearch Institute Hospital 12 de Octubre · ESUCLouvain · BEUniversité Claude Bernard Lyon 1 · FRUniversity of Bern · CH

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002377
6 · The paper itself

Abstract

backgroundSolid organ transplant (SOT) recipients are at risk of nocardiosis, a rare opportunistic bacterial infection, but prognosis and outcome of these patients are poorly defined. Our objectives were to identify factors associated with 1-year mortality after nocardiosis and describe the outcome of patients receiving short-course antibiotics (≤120 days).

methodsWe analyzed data from a multicenter European case-control study that included 117 SOT recipients with nocardiosis diagnosed between 2000 and 2014. Factors associated with 1-year all-cause mortality were identified using multivariable conditional logistic regression.

resultsOne-year mortality was 10-fold higher in patients with nocardiosis (16.2%, 19/117) than in control transplant recipients (1.3%, 3/233, P < .001). A history of tumor (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8), invasive fungal infection (OR, 1.3; 95% CI, 1.1-1.5), and donor age (OR, 1.0046; 95% CI, 1.0007-1.0083) were independently associated with 1-year mortality. Acute rejection in the year before nocardiosis was associated with improved survival (OR, 0.85; 95% CI, 0.73-0.98). Seventeen patients received short-course antibiotics (median duration 56 [24-120] days) with a 1-year success rate (cured and surviving) of 88% and a 5.9% risk of relapse (median follow-up 49 [6-136] months).

conclusionsOne-year mortality was 10-fold higher in SOT patients with nocardiosis than in those without. Four factors, largely reflecting general medical condition rather than severity and/or management of nocardiosis, were independently associated with 1-year mortality. Patients who received short-course antibiotic treatment had good outcomes, suggesting that this may be a strategy for further study.

Indexed as

AgedAnti-Bacterial AgentsCase-Control StudiesEuropeFemaleHumansInvasive Fungal InfectionsLogistic ModelsMaleMiddle AgedNocardia InfectionsOdds RatioOpportunistic InfectionsOrgan TransplantationPrognosisRetrospective StudiesAnti-Bacterial AgentsmortalityNocardiaopportunistic infections.organ transplantationprognosis

Identifiers

PMID28329348
PMCPMC10941331
OpenAlexW2583148229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.